FDA.reportPublic FDA data

NDC 66794-214-02 - Ceftriaxone

This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.

Product NDC
66794-214
Requested NDC
66794-214-02
Package NDCs from labels
66794-214-02, 66794-214-42
Manufacturer
Piramal Critical Care Inc | Piramal Critical Care Limited | Astral SteriTech Private Limited
Effective date
2022-12-24
Current FDA listing
Not matched in FDA.report NDC product tables

DailyMed Labels#

Label, Manufacturer, Effective date table
LabelManufacturerEffective dateType
Ceftriaxone - Piramal Critical Care Inc | Piramal Critical Care Limited | Astral SteriTech Private LimitedPiramal Critical Care Inc | Piramal Critical Care Limited | Astral SteriTech Private Limited2022-12-24HUMAN PRESCRIPTION DRUG LABEL

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
66794-214-422024-02-20C16284748780-11030e365-1cce-111a-e063-dadaa90a10e2CEFTRIAXONE FOR INJECTION, USP (For Intravenous or Intramuscular Use) Rx only To reduce the development of drug-resistant bacteria and maintain the effectiveness of ceftriaxone for injection, and other antibacterial drugs, ceftriaxone for injection should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria.
66794-214-422024-01-30C16284748780-11030e365-1cce-111a-e063-dadaa90a10e2CEFTRIAXONE FOR INJECTION, USP (For Intravenous or Intramuscular Use) Rx only To reduce the development of drug-resistant bacteria and maintain the effectiveness of ceftriaxone for injection, and other antibacterial drugs, ceftriaxone for injection should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria.

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
66794-214-02EA - Each66794-214be6813bb-1b7c-4d19-a13f-ed1be6508dd312019-09-05
66794-214-42EA - Each66794-21420ba1c98-04bb-441b-8e50-fce8e370d72712019-09-05

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 2 · 36 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Ceftriaxone SodiumCEFTRIAXONE SODIUMSportpharm LLCddbc3bf6-5bab-4851-ae5a-ef263cd8f2552026-07-23Warnings, Adverse reactionsExact identifier
unii: 023Z5BR09K
CeftriaxoneCEFTRIAXONEWG Critical Care, LLC86ec0a92-a552-4a6d-9125-a54f95e433922026-06-18Warnings, Adverse reactionsExact identifier
unii: 023Z5BR09K
Ceftriaxone SodiumCEFTRIAXONE SODIUMSportpharm LLC85ce4f8b-77e0-48bf-9f57-93f1478befa22026-04-24Warnings, Adverse reactionsExact identifier
unii: 023Z5BR09K
Ceftriaxone SodiumCEFTRIAXONE SODIUMSportpharm LLC9a937e47-8c36-4656-83e1-b3c18ed9bac32026-04-24Warnings, Adverse reactionsExact identifier
unii: 023Z5BR09K
Ceftriaxone SodiumCEFTRIAXONE SODIUMREMEDYREPACK INC.9c801096-ca61-4b29-a1e1-5f7e7813b1912026-02-06Warnings, Adverse reactionsExact identifier
unii: 023Z5BR09K
Ceftriaxone SodiumCEFTRIAXONE SODIUMQilu Pharmaceutical Co., Ltd.4cdf0743-c62b-4969-b9c9-4c6400644f6c2026-02-04Warnings, Adverse reactionsExact identifier
unii: 023Z5BR09K
Ceftriaxone SodiumCEFTRIAXONE SODIUMHospira, Inc128bb292-d174-4769-b3e6-9f16617f31e32026-01-22Warnings, Adverse reactionsExact identifier
unii: 023Z5BR09K
Ceftriaxone SodiumCEFTRIAXONE SODIUMHospira, Inc19141ccd-e66c-49a2-a794-0616028495a72026-01-19Warnings, Adverse reactionsExact identifier
unii: 023Z5BR09K
Ceftriaxone SodiumCEFTRIAXONE SODIUMHospira, Inc03283208-8616-4117-9d2b-aa8046017a4f2026-01-19Warnings, Adverse reactionsExact identifier
unii: 023Z5BR09K
Ceftriaxone SodiumCEFTRIAXONE SODIUMHospira, Inc365fc265-8e6c-432f-9fda-911f5f7fb4512026-01-16Warnings, Adverse reactionsExact identifier
unii: 023Z5BR09K
Ceftriaxone SodiumCEFTRIAXONE SODIUMHospira, Inc36c07ebf-b091-483e-b2c4-f0fc0c2b41862026-01-16Warnings, Adverse reactionsExact identifier
unii: 023Z5BR09K
CeftriaxoneCEFTRIAXONEWG Critical Care, LLC7bed9b33-29e3-4f04-9766-43a21c7ad47a2026-01-07Warnings, Adverse reactionsExact identifier
unii: 023Z5BR09K
CeftriaxoneCEFTRIAXONEWG Critical Care, LLCbefd73ff-cb3b-4543-8a8e-bdb9b7fc1ff02025-04-07Warnings, Adverse reactionsExact identifier
unii: 023Z5BR09K
Ceftriaxone SodiumCEFTRIAXONE SODIUMSandoz Inc53df951b-2eee-44b1-bae2-df7ed85bc0ed2025-02-28Warnings, Adverse reactionsExact identifier
unii: 023Z5BR09K
Ceftriaxone SodiumCEFTRIAXONE SODIUMSandoz Incde028434-46cf-44f6-8ac6-889c7c6943b32025-02-27Warnings, Adverse reactionsExact identifier
unii: 023Z5BR09K
CeftriaxoneCEFTRIAXONE SODIUMBaxter Healthcare Company4c5c2d3f-5038-41a1-a2fe-4dcd048dbac12024-10-07Warnings, Adverse reactionsExact identifier
unii: 023Z5BR09K
Ceftriaxone SodiumCEFTRIAXONE SODIUMA-S Medication Solutions53415af6-4072-4339-83e2-d870ae02a0e22024-08-20Warnings, Adverse reactionsExact identifier
unii: 023Z5BR09K
Ceftriaxone SodiumCEFTRIAXONE SODIUMA-S Medication Solutionsb642877e-0d36-4218-afe9-0a39f35b571d2024-03-27Warnings, Adverse reactionsExact identifier
unii: 023Z5BR09K
114183b5-e815-7bd9-e063-6294a90a328888312fc0-35d5-2945-e053-2a95a90a34bd2024-02-13Warnings, Adverse reactionsExact identifier
spl set id: 88312fc0-35d5-2945-e053-2a95a90a34bd
CeftriaxoneCEFTRIAXONECivica, Inc.96f3fc1e-84f4-4e9b-91ac-19a1692f227a2024-02-06Warnings, Adverse reactionsExact identifier
unii: 023Z5BR09K

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.